newsfilter
← Latest News
GlobeNewswire·

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,